# Clinical Efficacy of Indomethacin in Early Treatment of Acute Pancreatitis

> **NCT05637281** · NA · UNKNOWN · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 188 (estimated)

## Conditions studied

- Acute Pancreatitis
- Systemic Inflammatory Response Syndrome

## Interventions

- **DRUG:** Indometacin
- **OTHER:** conventional treatment

## Key facts

- **NCT ID:** NCT05637281
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-11
- **Primary completion:** 2023-12-11
- **Final completion:** 2023-12-11
- **Target enrollment:** 188 (ESTIMATED)
- **Last updated:** 2023-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05637281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05637281, "Clinical Efficacy of Indomethacin in Early Treatment of Acute Pancreatitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05637281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*